Please login to the form below

Not currently logged in
Email:
Password:

ADA 2014

This page shows the latest ADA 2014 news and features for those working in and with pharma, biotech and healthcare.

ADA: Novo says switching to Tresiba could reduce NHS costs

ADA: Novo says switching to Tresiba could reduce NHS costs

ADA: Novo says switching to Tresiba could reduce NHS costs. Real world data backs insulin’ s ability to reduce hypoglycaemia in people with diabetes. ... As with Novo and Tresiba, Sanofi is also banking on its new product's ability to reduce side

Latest news

More from news
Approximately 6 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
An agency called Owen

We’re an independent brand and marketing agency that believes our DNA is a little different from others. * A respectful,...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics